Literature DB >> 27829167

ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.

Byung-Chul Jeong1, Jung Ha Kim2, Kabsun Kim2, Inyoung Kim2, Semun Seong3, Nacksung Kim4.   

Abstract

Activating transcription factor 3 (ATF3), a member of the ATF/cAMP response element-binding protein family of transcription factors, has been implicated in the regulation of cell proliferation and differentiation. However, whether ATF3 is involved in osteoclast differentiation and activity has not been well-studied. In the present study, we examined the role of ATF3 in osteoclast differentiation and function. ATF3 expression was down-regulated during RANKL-induced osteoclast differentiation. Overexpression of ATF3 in bone marrow-derived monocyte/macrophage lineage cells (BMMs) promoted osteoclast differentiation and activity and strongly induced the expression of osteoclast genes encoding nuclear factor of activated T-cells c1 (NFATc1) and tartrate-resistant acid phosphatase (TRAP) compared to that in the control group. In contrast, small interfering RNA-mediated knockdown of ATF3 prevented the formation of multinucleated osteoclasts and markedly abrogated the expression of osteoclast marker genes. Mechanistically, ATF3 synergistically enhanced c-Fos- or NFAT-mediated transcriptional activity of the NFATc1 or TRAP promoter, respectively. Furthermore, ATF3 physically interacted with c-Fos and NFATc1 and enhanced the binding affinity of c-Fos and NFATc1 to the promoters. Interestingly, ATF3 is involved in calcium signaling during osteoclastogenesis. Taken together, these results suggest that ATF3 is a new co-factor of c-Fos and NFATc1 to activate osteoclast differentiation and activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activating transcription factor 3; Calcium signaling; Osteoclasts; RANKL

Mesh:

Substances:

Year:  2016        PMID: 27829167     DOI: 10.1016/j.bone.2016.11.005

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

1.  Systemic Dietary Hesperidin Modulation of Osteoclastogenesis, Bone Homeostasis and Periodontal Disease in Mice.

Authors:  Vinícius de Paiva Gonçalves; Marta Liliana Musskopf; Angeliz Rivera-Concepcion; Christina Yu; Sing Wai Wong; Stephen A Tuin; Yizu Jiao; Cristiano Susin; Luís Carlos Spolidorio; Patricia Almeida Miguez
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

2.  Effects and Mechanisms of Rhus chinensis Mill. Fruits on Suppressing RANKL-Induced Osteoclastogenesis by Network Pharmacology and Validation in RAW264.7 Cells.

Authors:  Yue Zheng; Lei Zhao; Junjie Yi; Shengbao Cai
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

3.  The ATF3-OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes.

Authors:  Jung Ha Kim; Kabsun Kim; Inyoung Kim; Semun Seong; Jeong-Tae Koh; Nacksung Kim
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

4.  Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.

Authors:  Min-Kyoung Song; Cheolkyu Park; Yong Deok Lee; Haemin Kim; Min Kyung Kim; Jun-Oh Kwon; Ja Hyun Koo; Min Sung Joo; Sang Geon Kim; Hong-Hee Kim
Journal:  J Cell Mol Med       Date:  2017-10-27       Impact factor: 5.310

5.  Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.

Authors:  Peng Sun; Qichang Yang; Yanben Wang; Jiaxuan Peng; Kangxian Zhao; Yewei Jia; Tan Zhang; Xuanyuan Lu; Weiqi Han; Yu Qian
Journal:  Drug Des Devel Ther       Date:  2020-10-09       Impact factor: 4.162

6.  Protocatechualdehyde Inhibits the Osteoclast Differentiation of RAW264.7 and BMM Cells by Regulating NF-κB and MAPK Activity.

Authors:  Yunyun Qu; Xin Liu; Shuai Zong; Huanxin Sun; Shuang Liu; Yueran Zhao
Journal:  Biomed Res Int       Date:  2021-07-16       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.